hotspot -WSS

hotspot

author：focus 2025-10-04 07:30:20 - browse：7916

By some measures, private equity investment lagged in 2023, a year marked by growing distress and high-profile downfalls among private equity-backed health care companies.

Even so, three sectors still managed to see strong deal flow and prices: med spa, cardiology, and clinical trial sites, according to a new PitchBook report analyzing private equity investments in health care services in 2023. Each of the three niches continue to generate buzz among investors, even as other areas fizzle.

It’s not that those three industries are perfect fits for private equity, it’s that the more obvious areas like autism therapists and physician practices are struggling with high interest rates and regulatory scrutiny, said Rebecca Springer, PitchBook’s lead health care analyst.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： Readout Newsletter: WuXi and Congress, Boundless Bio, etc.

hotspot

WSS

The Readout: Lenmeldy, GLP

Food as medicine: Medically tailored meals may get standardized

Wegovy leads to weight loss. Can it treat depression, too?

New clues to why women have higher risk of autoimmune disorders

Readout Newsletter: Merck, Vertex, and Viking updates

There's no autism epidemic. It's an autism diagnosis epidemic

hotspot

hotspot

leisure time

Cancer drug shortages should be causing more outrage

Eliminate the waiting period for sterilization covered by Medicaid

New air purifier tech could be key to improving indoor air quality

Readout Newsletter: Blackstone Life Sciences, Merck, Bluebird Bio

Supreme Court strikes down use of affirmative action

Patient advocates debate FDA's accelerated approval process

As demand for Covid shots wanes, Moderna seeks its next success

Steward Health Care has deal to sell doctor network to UnitedHealth

How to save PrEP access — and even expand it

Readout Newsletter: Cardior, Regeneron, Nuvation, Dyne and more

knowledge

Supreme Court mifepristone arguments center on docs' right to sue

How generative AI ratchets up security threats for health systems

Readout Newsletter: Cardior, Regeneron, Nuvation, Dyne and more

Scientists boost immune system in aging mice by making it youthful

Merck CEO won’t testify in Senate, citing no expertise in drug prices

Vertex Pharmaceuticals may move headquarters in Boston

focus

hotspot

hotspot

leisure time